- Home
- OSUR vs AVIR Comparison
OSUR vs AVIR Comparison
Compare OSUR & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | AVIR |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.6M | 429.1M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OSUR | AVIR |
|---|---|---|
| Price | $3.52 | $5.29 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 433.7K | 216.2K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | $167,064,000.00 | ★ $351,367,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.08 | $2.78 |
| 52 Week High | $4.58 | $6.45 |
Technical Indicators
Market Signals| Indicator | OSUR | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 44.25 | 48.40 |
| Support Level | $2.86 | $5.13 |
| Resistance Level | $4.29 | $5.79 |
| Average True Range (ATR) | 0.12 | 0.20 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 66.36 | 25.56 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.